Oleksandra Prysyazhna

1PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jul 10, 2025
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2.

Hyun-Ju Cho, Joy Smith, Christopher H Switzer

Pageof 1

Frequent Collaborators

1 joint publications

Eleni Louka

1 joint publications

Rebecca L Charles

1 joint publications

Daniel Simoes de Jesus

1 joint publications

Xiaoke Yin

1 joint publications

Valle Morales

1 joint publications

Katiuscia Bianchi

1 joint publications

Vinothini Rajeeve

1 joint publications

Pedro R Cutillas

1 joint publications

Philip Eaton

Frequent Collaborators

1 joint publications

Eleni Louka

1 joint publications

Rebecca L Charles

1 joint publications

Daniel Simoes de Jesus

1 joint publications

Xiaoke Yin

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

6.3K
See more related videos

Top Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on : Jul 17, 2020

6.3K
See more related videos